Epidermal growth factor receptor inhibitor in advanced basal cell carcinoma

Cetuximab can be used for the treatment of advanced basal cell carcinoma, especially when the patient cannot tolerate routine chemotherapy. Future studies are needed to confirm it.

Detalles Bibliográficos
Autores principales: Amirabadi, Amir, Alami, Amirhosein, Ahanchian, Hamid, Ariaee, Nazila, Moazzen, Nasrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142310/
https://www.ncbi.nlm.nih.gov/pubmed/34084482
http://dx.doi.org/10.1002/ccr3.4021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142310/
https://www.ncbi.nlm.nih.gov/pubmed/34084482
http://dx.doi.org/10.1002/ccr3.4021

Ejemplares similares